Greece

Greece has rapidly emerged as a premier Mediterranean life sciences hub, transitioning from a regional player to a globally recognized center for pharmaceutical manufacturing and biotech innovation.

The nation is best known for its robust pharmaceutical sector, which stands as its second-largest export industry, delivering high-quality generics and biosimilars to over 80 countries worldwide.

Driven by the "clawback-for-investment" scheme and Law 5162/2024, Greece offers aggressive R&D tax incentives that have catalyzed a surge in clinical trials and private research investments.

The healthtech and medtech landscapes are flourishing through the Elevate Greece ecosystem, where startups utilize advanced AI-driven diagnostics and digital health solutions to modernize patient care.

Academic excellence remains a cornerstone, with prestigious institutions like the Foundation for Research and Technology - Hellas (FORTH) and the National Centre for Scientific Research "Demokritos" fostering world-class biomedical research and technology transfer.

Strategically positioned as a gateway between Europe, Asia and Africa, Greece provides a highly skilled, multilingual workforce and specialized logistics infrastructure for temperature-sensitive medical products.

Furthermore, the country is expanding its footprint in precision medicine and genomics, leveraging a rich genetic database and a modernized national healthcare system.

With record-breaking venture capital inflows and a commitment to digital transformation, the Greek life sciences ecosystem offers unparalleled opportunities for international collaboration and sustainable growth in the global healthcare market.